跳至主要内容
临床试验/NCT01669161
NCT01669161已完成不适用

A Proof-of-Concept Pilot Study Assessing Vagus Nerve Stimulation (VNS) Paired With Rehabilitation for Improved Upper Limb Function After Stroke (MicroTransponder's Vivistim System)

MicroTransponder Inc.1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2013年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
21
试验地点
1
主要终点
Safety

研究概览

简要总结

Patients (UK only) at least 6 months post stroke, with upper limb deficits, may enroll. Patients will be randomized to one of two groups - a group implanted with a device that allows pairing VNS with rehabilitation and a group that only receives rehabilitation (no implant). Patients have two baseline evaluations, one evaluation after implant but before initiation of treatment, and then six weeks of rehabilitation or rehabilitation + VNS, followed by post acute therapy evaluations at 1, 7, and 30 days after the 6-weeks of treatment. The intent is to assess safety and provide preliminary effectiveness information for VNS for upper limb functional improvement after stroke. Implanted patients may receive longer-term treatment and follow-up after the acute study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Major Inclusion Criteria:
  • •History of unilateral supratentorial ischemic stroke that occurred at least 6 months prior
  • •Age > 18 years and < 80 years
  • •Right or left sided weakness of upper extremity

排除标准

  • •Hemorrhagic stroke
  • •Any deficits in language or attention that interferes with reasonable study participation
  • •Presence of significant apraxia
  • •Profound Sensory loss
  • •Active major neurological or psychiatric diagnosis that would likely interfere with study protocol including alcohol or drug abuse

研究组 & 干预措施

VNS

Experimental

VNS (vagus nerve stimulation) paired with rehabilitation as provided by the Vivistim System.

干预措施: Vivistim System (Device)

Rehab Only

Active Comparator

Rehabilitation only (no implant, no VNS)

干预措施: Rehab Only (Other)

结局指标

主要结局

Safety

时间窗: 6-weeks

Assessment of adverse events and serious adverse events.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验